MX348663B - Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. - Google Patents
Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009.Info
- Publication number
- MX348663B MX348663B MX2009009565A MX2009009565A MX348663B MX 348663 B MX348663 B MX 348663B MX 2009009565 A MX2009009565 A MX 2009009565A MX 2009009565 A MX2009009565 A MX 2009009565A MX 348663 B MX348663 B MX 348663B
- Authority
- MX
- Mexico
- Prior art keywords
- outbreak
- against influenza
- escherichia coli
- influenza
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a una vacuna recombinante expresable en cepas de Escherichia coli caracterizada por contener la Sec ID No. 1 del fragmento no glicosilado de la hemaglutinina del virus de la Influenza A H1N1/2009, con un extremo N-terminal de 3 a 12 histidinas (Sec. ID No. 2 y la secuencia Sec ID No.3).
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009009565A MX348663B (es) | 2009-09-08 | 2009-09-08 | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. |
PCT/MX2010/000027 WO2011031125A1 (es) | 2009-09-08 | 2010-03-26 | Proteínas recombinantes expresables en escherichia coli como ingredientes activos de vacunas contra influenza a h1n1 brote 2009 y su proceso de producción |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009009565A MX348663B (es) | 2009-09-08 | 2009-09-08 | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2009009565A MX2009009565A (es) | 2009-11-10 |
MX348663B true MX348663B (es) | 2017-05-26 |
Family
ID=42025992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009565A MX348663B (es) | 2009-09-08 | 2009-09-08 | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX348663B (es) |
WO (1) | WO2011031125A1 (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1831259A2 (en) * | 2004-12-21 | 2007-09-12 | Vaxinnate Corporation | Compositions of influenza viral proteins and methods of use thereof |
-
2009
- 2009-09-08 MX MX2009009565A patent/MX348663B/es active IP Right Grant
-
2010
- 2010-03-26 WO PCT/MX2010/000027 patent/WO2011031125A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011031125A1 (es) | 2011-03-17 |
MX2009009565A (es) | 2009-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103732749B (zh) | 计算优化的宽反应性的h1n1流感抗原 | |
NZ701881A (en) | Vaccines for hsv-2 | |
US10736956B2 (en) | Influenza virus vaccination regimens | |
WO2009026397A3 (en) | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods | |
NZ597769A (en) | Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli | |
RS20080174A (en) | Canine influenza virus and related compositions and methods of use | |
WO2011143262A3 (en) | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses | |
BR112013026706A2 (pt) | composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
KR20100067094A (ko) | 인플루엔자 항원 수송 벡터 및 구조물 | |
NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
MX2009008118A (es) | Polipeptido e2 del virus del papiloma usado para vacunacion. | |
US11304989B2 (en) | Peptides for use in the treatment of viral infections | |
EA201491513A1 (ru) | Рекомбинантные штаммы escherichia coli | |
GB201303983D0 (en) | Drug and method for the prophylaxis of HIV infection and for the prophylaxis and treatment of diseases caused by or associated with HIV, including AIDS | |
WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
CN115003328A (zh) | 重组神经氨酸酶及其用途 | |
JP5343079B2 (ja) | トリインフルエンザウイルス抗原及び経口投与で有効な粘膜アジュバントを併用したトリインフルエンザワクチンの追加免疫方法 | |
Jazi et al. | In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine | |
NZ712713A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
JP2013504519A5 (es) | ||
BR112014007491A2 (pt) | sequências de aminoácidos para o controle de patógenos | |
MX348663B (es) | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. | |
EA033242B1 (ru) | Усовершенствованные нуклеиновые кислоты и белки вируса человеческой папилломы, вакцины и композиции на их основе и способы индукции иммунного ответа против впч с их применением | |
UA99117C2 (ru) | Белок h5 вируса гриппа, молекула нуклеиновой кислоты и кодирующий её вектор, и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |